Autoimmune encephalitis associated with COVID-19: A systematic review.
Autoimmune encephalitis
COVID-19
Systematic review
Journal
Multiple sclerosis and related disorders
ISSN: 2211-0356
Titre abrégé: Mult Scler Relat Disord
Pays: Netherlands
ID NLM: 101580247
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
27
04
2021
revised:
17
01
2022
accepted:
31
03
2022
pubmed:
27
4
2022
medline:
15
6
2022
entrez:
26
4
2022
Statut:
ppublish
Résumé
There are increasing reports of COVID-19 related neurological complications which may be due to direct viral invasion, or immune mediated inflammatory diseases such as autoimmune encephalitis and ADEM (acute demyelinating encephalomyelitis). In this study, a systematic review is presented of the reported cases infected by the COVID-19 who were diagnosed with various forms of autoimmune encephalitis (AE). The authors searched three databases including PubMed, Scopus, and Web of science for extracting original articles on coronavirus/ COVID-19 and AE. Eighteen articles were considered in this study, including 15 case reports, and three case series with a total of 81 patients. Among the studies, 19 cases were reported with AE including 7 (37%) cases of limbic encephalitis, 5 (26%) patients with anti-N-methyl-d-aspartate (NMDA) receptor encephalitis, 2 (11%) with AE presenting as new-onset refractory status epilepticus (NORSE), 1 (5%) case of steroid-responsive encephalitis, and 4 (21%) cases with an unknown type of AE. Our systematic review revealed evidence on AE development in patients infected with the COVID-19. Clinicians should be aware of the possible diagnosis of AE when considering other neurological differential diagnosis in SARS-CoV-2 infected patients.
Identifiants
pubmed: 35472834
pii: S2211-0348(22)00302-9
doi: 10.1016/j.msard.2022.103795
pmc: PMC8983076
pii:
doi:
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
103795Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.
Références
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Childs Nerv Syst. 2021 Jan;37(1):1-4
pubmed: 30834964
Ann Neurol. 2020 Aug;88(2):423-427
pubmed: 32418288
Brain Behav Immun. 2020 Jul;87:179-181
pubmed: 32454137
Lancet Neurol. 2018 Sep;17(9):760-772
pubmed: 30049614
Brain Behav Immun. 2020 Aug;88:68-70
pubmed: 32531427
J Neurol. 2021 Oct;268(10):3569-3573
pubmed: 33709220
J Neurol Neurosurg Psychiatry. 2020 Nov;91(11):1229-1230
pubmed: 32661082
Can J Neurol Sci. 2021 May;48(3):430-432
pubmed: 32938510
J Neuroimmunol. 2016 Aug 15;297:141-7
pubmed: 27397087
J Infect Dis. 2021 Jan 4;223(1):28-37
pubmed: 32986824
J Neurol Neurosurg Psychiatry. 2020 Sep;91(9):1013-1014
pubmed: 32636212
J Med Virol. 2020 Apr;92(4):401-402
pubmed: 31950516
J Neurol. 2021 Mar;268(3):751-757
pubmed: 32734353
Childs Nerv Syst. 2021 Jul;37(7):2305-2312
pubmed: 33751228
N Engl J Med. 2020 Jun 4;382(23):2268-2270
pubmed: 32294339
Seizure. 2020 Oct;81:18-20
pubmed: 32688169
Lancet Neurol. 2020 Nov;19(11):919-929
pubmed: 33031735
J Med Virol. 2020 Apr;92(4):418-423
pubmed: 31967327
N Engl J Med. 2020 Jun 25;382(26):2574-2576
pubmed: 32302082
Pediatr Neurol. 2021 Jan;114:75-76
pubmed: 33246132
Cells. 2020 Oct 27;9(11):
pubmed: 33120941
Br J Haematol. 2020 Jul;190(1):29-31
pubmed: 32374906
J Nucl Med. 2020 Dec;61(12):1726-1729
pubmed: 32709734
Medicine (Baltimore). 2020 Sep 04;99(36):e21428
pubmed: 32898993